Sports
Verona Pharma Reports Third Quarter 2024 Financial Results And Provides Corporate Update
(MENAFN - GlobeNewsWire - Nasdaq) OhtuvayreTM (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more than 2,200 unique prescribers and ...
By: menafn
- Nov 04 2024
- 0
- 0 Views
Share this page
Guest Posts by Easy Branches
